1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope
2. Executive Summary
2.1. Market Snapshot: Global Non-Hodgkin Lymphoma Therapeutics Market
2.2. Global Non-Hodgkin Lymphoma Therapeutics Market, By Type of Therapy
2.3. Global Non-Hodgkin Lymphoma Therapeutics Market, By Cell Type
2.4. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Non-Hodgkin Lymphoma Therapeutics Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type of Therapy
3.5.2. Cell Type
3.5.3. Geography
4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Type of Therapy Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend
5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others
6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa
7. Global Non-Hodgkin Lymphoma Therapeutics Market, By Type of Therapy
7.1. Global Non-Hodgkin Lymphoma Therapeutics Market Overview, by Type of Therapy
7.1.1. Global Non-Hodgkin Lymphoma Therapeutics Market Revenue Share, By Type of Therapy, 2022 Vs 2030 (in %)
7.2. Chemotherapy
7.2.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region, 2017-2030 (US$ Bn)
7.3. Radiation Therapy
7.3.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region, 2017-2030 (US$ Bn)
7.4. Targeted Therapy
7.4.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region, 2017-2030 (US$ Bn)
7.5. Other Types of Therapies
7.5.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region, 2017-2030 (US$ Bn)
8. Global Non-Hodgkin Lymphoma Therapeutics Market, By Cell Type
8.1. Global Non-Hodgkin Lymphoma Therapeutics Market Overview, by Cell Type
8.1.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Cell Type, 2022 vs 2030 (in %)
8.2. B-cell Lymphomas
8.2.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region, 2017-2030 (US$ Bn)
8.3. T-cell Lymphoma
8.3.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region, 2017-2030 (US$ Bn)
9. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region
9.1. Global Non-Hodgkin Lymphoma Therapeutics Market Overview, by Region
9.1.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Region, 2022 vs 2030 (in%)
9.2. Type of Therapy
9.2.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Type of Therapy, 2017-2030 (US$ Bn)
9.3. Cell Type
9.3.1. Global Non-Hodgkin Lymphoma Therapeutics Market, By Cell Type, 2017-2030 (US$ Bn)
10. North America Non-Hodgkin Lymphoma Therapeutics Market Analysis
10.1. North America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. North America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. North America Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2017-2030 (US$ Bn)
10.3.1. North America Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2022 Vs 2030 (in%)
10.3.2. U.S.
10.3.2.1. U.S. Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. U.S. Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
10.3.2.3. U.S. Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
10.3.3. Canada
10.3.3.1. Canada Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. Canada Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
10.3.3.3. Canada Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
10.3.4. Mexico
10.3.4.1. Mexico Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. Mexico Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
10.3.4.3. Mexico Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
11. Europe Non-Hodgkin Lymphoma Therapeutics Market Analysis
11.1. Europe Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Europe Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Europe Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Europe Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2022 Vs 2030 (in%)
11.3.2. Germany
11.3.2.1. Germany Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Germany Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
11.3.2.3. Germany Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
11.3.3. France
11.3.3.1. France Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. France Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
11.3.3.3. France Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
11.3.4. UK
11.3.4.1. UK Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.4.2. UK Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
11.3.4.3. UK Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
11.3.5. Italy
11.3.5.1. Italy Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.5.2. Italy Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
11.3.5.3. Italy Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
11.3.6. Spain
11.3.6.1. Spain Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.6.2. Spain Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
11.3.6.3. Spain Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
11.3.7. Rest of Europe
11.3.7.1. Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.7.2. Rest of Europe Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
11.3.7.3. Rest of Europe Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
12. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Analysis
12.1. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2017-2030 (US$ Bn)
12.3.1. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2022 Vs 2030 (in%)
12.3.2. China
12.3.2.1. China Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. China Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
12.3.2.3. China Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
12.3.3. Japan
12.3.3.1. Japan Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Japan Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
12.3.3.3. Japan Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
12.3.4. India
12.3.4.1. India Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.4.2. India Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
12.3.4.3. India Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
12.3.5. South Korea
12.3.5.1. South Korea Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.5.2. South Korea Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
12.3.5.3. South Korea Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
12.3.6. South-East Asia
12.3.6.1. South-East Asia Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.6.2. South-East Asia Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
12.3.6.3. South-East Asia Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
12.3.7. Rest of Asia Pacific
12.3.7.1. Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.7.2. Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
12.3.7.3. Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
13. Latin America Non-Hodgkin Lymphoma Therapeutics Market Analysis
13.1. Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2017-2030 (US$ Bn)
13.3.1. Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2022 Vs 2030 (in%)
13.3.2. Brazil
13.3.2.1. Brazil Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.2.2. Brazil Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
13.3.2.3. Brazil Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
13.3.3. Argentina
13.3.3.1. Argentina Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.3.2. Argentina Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
13.3.3.3. Argentina Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
13.3.4. Rest of Latin America
13.3.4.1. Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.4.2. Rest of Latin America Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
13.3.4.3. Rest of Latin America Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
14. Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market Analysis
14.1. Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2017-2030 (US$ Bn)
14.3.1. Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2022 Vs 2030 (in%)
14.3.2. GCC Countries
14.3.2.1. GCC Countries Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.2.2. GCC Countries Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
14.3.2.3. GCC Countries Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
14.3.3. South Africa
14.3.3.1. South Africa Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.3.2. South Africa Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
14.3.3.3. South Africa Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
14.3.4. Rest of Middle East and Africa
14.3.4.1. Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.4.2. Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics, By Type of Therapy, 2017-2030 (US$ Bn)
14.3.4.3. Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics, By Cell Type, 2017-2030 (US$ Bn)
15. Company Profiles
15.1. AstraZeneca PLC
15.1.1. Company Overview
15.1.2. Products/Services Portfolio
15.1.3. Geographical Presence
15.1.4. Financial Summary
15.1.4.1. Market Revenue and Net Profit (2019-2022)
15.1.4.2. Business Segment Revenue Analysis
15.1.4.3. Geographical Revenue Analysis
15.2. Baxter International Inc.
15.3. Bayer AG
15.4. Bristol Myers Squibb Company
15.5. Eli Lilly and Company
15.6. F. Hoffmann La-Roche Ltd
15.7. GlaxoSmithKline PLC
15.8. Seattle Genetics
15.9. Teva Pharmaceuticals
15.10. Takeda Pharmaceutical Company Limited
15.11. Spectrum Pharmaceuticals Inc.
15.12. Janssen Pharmaceuticals Inc.
List of Figures
FIG. 1 Global Non-Hodgkin Lymphoma Therapeutics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Non-Hodgkin Lymphoma Therapeutics Market Segmentation
FIG. 4 Global Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2022 (US$ Bn)
FIG. 5 Global Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2022 (US$ Bn)
FIG. 6 Global Non-Hodgkin Lymphoma Therapeutics Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Type of Therapy, 2022
FIG. 8 Attractive Investment Proposition, by Cell Type, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Non-Hodgkin Lymphoma Therapeutics Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Non-Hodgkin Lymphoma Therapeutics Market Manufacturers, 2022
FIG. 12 Global Non-Hodgkin Lymphoma Therapeutics Market Value Contribution, By Type of Therapy, 2022 & 2030 (Value %)
FIG. 13 Global Non-Hodgkin Lymphoma Therapeutics Market, by Chemotherapy, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Non-Hodgkin Lymphoma Therapeutics Market, by Radiation Therapy, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Non-Hodgkin Lymphoma Therapeutics Market, by Targeted Therapy, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Non-Hodgkin Lymphoma Therapeutics Market, by Other Types of Therapies, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Non-Hodgkin Lymphoma Therapeutics Market Value Contribution, By Cell Type, 2022 & 2030 (Value %)
FIG. 18 Global Non-Hodgkin Lymphoma Therapeutics Market, by B-cell Lymphomas, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Non-Hodgkin Lymphoma Therapeutics Market, by T-cell Lymphoma, 2017-2030 (US$ Bn)
FIG. 20 North America Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 21 U.S. Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 22 Canada Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 23 Europe Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 24 Germany Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 25 France Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 26 U.K. Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 27 Italy Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 28 Spain Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 29 Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 30 Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 31 China Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 32 Japan Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 33 India Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 34 South Korea Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 35 South-East Asia Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 36 Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 37 Latin America Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 38 Brazil Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 39 Mexico Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 40 Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 41 Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 42 GCC Countries Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 43 South Africa Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
FIG. 44 Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, 2017-2030 (US$ Bn)
List of Tables
TABLE 1 Market Snapshot: Global Non-Hodgkin Lymphoma Therapeutics Market
TABLE 2 Global Non-Hodgkin Lymphoma Therapeutics Market: Market Drivers Impact Analysis
TABLE 3 Global Non-Hodgkin Lymphoma Therapeutics Market: Market Restraints Impact Analysis
TABLE 4 Global Non-Hodgkin Lymphoma Therapeutics Market, by Competitive Benchmarking, 2022
TABLE 5 Global Non-Hodgkin Lymphoma Therapeutics Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Non-Hodgkin Lymphoma Therapeutics Market, by Key Strategies Analysis, 2022
TABLE 7 Global Non-Hodgkin Lymphoma Therapeutics Market, by Chemotherapy, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Non-Hodgkin Lymphoma Therapeutics Market, by Chemotherapy, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Non-Hodgkin Lymphoma Therapeutics Market, by Radiation Therapy, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Non-Hodgkin Lymphoma Therapeutics Market, by Radiation Therapy, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Non-Hodgkin Lymphoma Therapeutics Market, by Targeted Therapy, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Non-Hodgkin Lymphoma Therapeutics Market, by Targeted Therapy, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Non-Hodgkin Lymphoma Therapeutics Market, by Other Types of Therapies, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Non-Hodgkin Lymphoma Therapeutics Market, by Other Types of Therapies, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Non-Hodgkin Lymphoma Therapeutics Market, by B-cell Lymphomas, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Non-Hodgkin Lymphoma Therapeutics Market, by B-cell Lymphomas, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Non-Hodgkin Lymphoma Therapeutics Market, by T-cell Lymphoma, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Non-Hodgkin Lymphoma Therapeutics Market, by T-cell Lymphoma, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 20 Global Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 21 Global Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 22 Global Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 23 Global Non-Hodgkin Lymphoma Therapeutics Market, by Region, 2017-2022 (US$ Bn)
TABLE 24 Global Non-Hodgkin Lymphoma Therapeutics Market, by Region, 2023-2030 (US$ Bn)
TABLE 25 North America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 26 North America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 27 North America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 28 North America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 29 North America Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2017-2022 (US$ Bn)
TABLE 30 North America Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2023-2030 (US$ Bn)
TABLE 31 United States Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 32 United States Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 33 United States Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 34 United States Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 35 Canada Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 36 Canada Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 37 Canada Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 38 Canada Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 39 Mexico Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 40 Mexico Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 41 Mexico Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 42 Mexico Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 43 Europe Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 44 Europe Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 45 Europe Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 46 Europe Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 47 Europe Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2017-2022 (US$ Bn)
TABLE 48 Europe Non-Hodgkin Lymphoma Therapeutics Market, by Country, 2023-2030 (US$ Bn)
TABLE 49 Germany Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 50 Germany Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 51 Germany Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 52 Germany Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 53 France Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 54 France Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 55 France Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 56 France Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 57 United Kingdom Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 58 United Kingdom Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 59 United Kingdom Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 60 United Kingdom Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 61 Italy Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 62 Italy Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 63 Italy Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 64 Italy Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 65 Spain Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 66 Spain Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 67 Spain Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 68 Spain Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 69 Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 70 Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 71 Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 72 Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 73 Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 74 Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 75 Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 76 Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 77 China Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 78 China Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 79 China Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 80 China Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 81 Japan Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 82 Japan Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 83 Japan Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 84 Japan Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 85 India Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 86 India Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 87 India Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 88 India Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 89 South Korea Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 90 South Korea Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 91 South Korea Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 92 South Korea Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 93 South-East Asia Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 94 South-East Asia Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 95 South-East Asia Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 96 South-East Asia Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 97 Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 98 Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 99 Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 100 Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 101 Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 102 Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 103 Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 104 Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 105 Brazil Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 106 Brazil Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 107 Brazil Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 108 Brazil Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 109 Argentina Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 110 Argentina Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 111 Argentina Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 112 Argentina Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 113 Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 114 Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 115 Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 116 Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 117 Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 118 Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 119 Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 120 Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 121 GCC Countries Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 122 GCC Countries Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 123 GCC Countries Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 124 GCC Countries Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 125 South Africa Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 126 South Africa Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 127 South Africa Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 128 South Africa Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)
TABLE 129 Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2017-2022 (US$ Bn)
TABLE 130 Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Type of Therapy, 2023-2030 (US$ Bn)
TABLE 131 Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2017-2022 (US$ Bn)
TABLE 132 Rest of Middle East and Africa Non-Hodgkin Lymphoma Therapeutics Market, by Cell Type, 2023-2030 (US$ Bn)